March 3, 2026

Integra LifeSciences Holdings C (IART) Stock Analysis: Evaluating a 45% Upside Potential Amidst Market Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART) remains a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Princeton, New Jersey, Integra focuses on manufacturing and..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Potential 36% Upside for Investors in Pain Management Solutions

Investors focusing on the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) a compelling option, particularly given the company’s strong foothold in non-opioid pain management solutions. With a market..

Disc Medicine, Inc. (IRON) Stock Analysis: A 50% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON) stands out in the healthcare sector with a promising outlook in the biotechnology industry. Despite its current trading price of $66.54, the company offers a..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: 136% Potential Upside Captivates Investor Interest

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising portfolio and remarkable potential upside. Headquartered in Bedford, Massachusetts,..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring a 19% Upside Potential

Investors looking for growth opportunities in the healthcare sector may find Amneal Pharmaceuticals, Inc. (NYSE: AMRX) an intriguing candidate. This global biopharmaceutical company, with a market cap of $4.33 billion,..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 113.65% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a leading biopharmaceutical company based in China, stands at a pivotal moment in its journey. With an impressive market cap of $2.06 billion, Zai Lab..

PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Unveiling the 23.55% Potential Upside in Healthcare Robotics

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is steadily carving its niche in the healthcare sector, specifically within the medical devices industry. Headquartered in San Jose, California, the company focuses on innovative..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook Reveals 19.63% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a key player in the biotechnology sector, is capturing investor interest with its promising potential upside of 19.63%. Headquartered in Edmonton, Canada, Aurinia is dedicated..

Guardian Pharmacy Services, Inc (GRDN): A Strong Buy with Promising Growth Potential in the Healthcare Sector

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, operates within the medical care facilities industry, focusing on long-term health care facilities (LTCFs) across the United..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring 27% Potential Upside in Healthcare Innovation

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Founded in 2014 and headquartered in Kirkland, Washington, Kestra..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A 26.86% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH) has been garnering attention among investors, particularly those with an interest in the healthcare sector. With a market capitalization of $1.26 billion, this Houston-based..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 33.56% Potential Upside in the Medical Devices Sector

AdaptHealth Corp. (NASDAQ: AHCO) stands as a significant player in the U.S. healthcare landscape, operating within the medical devices industry. Despite facing certain operational challenges, the company offers intriguing potential..

Novavax, Inc. (NVAX) Stock Analysis: Evaluating a 36% Potential Upside in a Volatile Biotech Sector

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors as it navigates the complexities of vaccine development and commercialization. With a market..

Neogen Corporation (NEOG) Stock Analysis: Navigating Growth Prospects Amid Market Challenges

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector specializing in medical devices, has captured investor attention with its diverse portfolio focused on food and animal safety products...

Privia Health Group, Inc. (PRVA) Stock Analysis: A 31.8% Upside Lures Investors in the Booming Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is capturing the attention of investors with its innovative approach to physician enablement and a promising potential..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring the 33% Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is a dynamic player in the biotechnology sector, headquartered in Cambridge, Massachusetts. The company is renowned for its innovative approach to developing therapies in the..

Viridian Therapeutics, Inc. (VRDN): Investor Outlook on a Biotech Powerhouse with 38% Upside Potential

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has emerged as a compelling player in the biotechnology sector with its innovative approach to addressing serious and rare diseases. With a market capitalization of..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Strong Buy Ratings Signal Potential 73% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing investor interest with its significant growth potential in the biotechnology sector. The company, with its $4.44 billion market cap, is a clinical-stage biopharmaceutical..

Evotec SE (EVO) Stock Analysis: Exploring a Potential 67.92% Upside Amidst Financial Challenges

Evotec SE (EVO) presents a compelling case for investors willing to navigate the complexities of the healthcare sector, specifically within drug manufacturing. Headquartered in Hamburg, Germany, Evotec operates in both..

Dynavax Technologies Corporation (DVAX): Investor Outlook with a Focus on Revenue Growth and Market Position

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector with a robust focus on vaccine development and commercialization. As a commercial-stage biopharmaceutical company, Dynavax has carved a..

Search

Funds

March 3, 2026

Search

Funds

March 3, 2026

FTSE 100

Funds